Your browser doesn't support javascript.
loading
Correction: Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer.
Rätze, Max A K; Koorman, Thijs; Sijnesael, Thijmen; Bassey-Archibong, Blessing; van de Ven, Robert; Enserink, Lotte; Visser, Daan; Jaksani, Sridevi; Viciano, Ignacio; Bakker, Elvira R M; Richard, François; Tutt, Andrew; O'Leary, Lynda; Fitzpatrick, Amanda; Roca-Cusachs, Pere; van Diest, Paul J; Desmedt, Christine; Daniel, Juliet M; Isacke, Clare M; Derksen, Patrick W B.
Affiliation
  • Rätze MAK; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Koorman T; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Sijnesael T; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Bassey-Archibong B; Department of Biology, McMaster University, Hamilton, ON, Canada.
  • van de Ven R; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Enserink L; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Visser D; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Jaksani S; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Viciano I; Institute for Bioengineering of Catalonia (IBEC), the Barcelona Institute of Technology (BIST), Barcelona, Spain.
  • Bakker ERM; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Richard F; Laboratory for Translational Breast Cancer Research, Katholieke Universiteit, Leuven, Belgium.
  • Tutt A; The Breast Cancer Now Research Unit, King's College London, London, United Kingdom.
  • O'Leary L; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.
  • Fitzpatrick A; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.
  • Roca-Cusachs P; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.
  • van Diest PJ; Institute for Bioengineering of Catalonia (IBEC), the Barcelona Institute of Technology (BIST), Barcelona, Spain.
  • Desmedt C; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Daniel JM; Laboratory for Translational Breast Cancer Research, Katholieke Universiteit, Leuven, Belgium.
  • Isacke CM; Department of Biology, McMaster University, Hamilton, ON, Canada.
  • Derksen PWB; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.
Oncogene ; 41(26): 3507-3509, 2022 Jun.
Article de En | MEDLINE | ID: mdl-35610485
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Oncogene Sujet du journal: BIOLOGIA MOLECULAR / NEOPLASIAS Année: 2022 Type de document: Article Pays d'affiliation: Pays-Bas
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Oncogene Sujet du journal: BIOLOGIA MOLECULAR / NEOPLASIAS Année: 2022 Type de document: Article Pays d'affiliation: Pays-Bas